Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
Table of Contents
Sexual Health

Sexual Health

Volume 19 Number 6 2022


Despite termination of pregnancy decriminalisation in 2018 in Queensland, people accessing this service continue to face inequitable barriers such as interpersonal violence, sexual and reproductive education, stigma, and affordability. By examining the experiences of people seeking assistance from a counselling service, we highlight how these barriers intersect to undermine reproductive rights, even in a decriminalised context. All-options pregnancy counselling services play a vital role in supporting access, but inclusive multisectoral action is needed to eliminate barriers to comprehensive care.

SH22101Increased awareness of event-driven PrEP and knowledge of how to use it: results from a cross-sectional survey of gay and bisexual men in Australia

Curtis Chan 0000-0002-9581-1011, Doug Fraser 0000-0003-4521-4697, Andrew E. Grulich 0000-0002-3269-1032, Steven Philpot 0000-0002-5398-5793, Matthew Vaughan, Michael Wacher and Benjamin R. Bavinton 0000-0001-5834-8278
pp. 501-508

Event-driven pre-exposure prophylaxis (ED-PrEP) is effective at preventing HIV among cis gay and bisexual men. We found in a survey of gay and bisexual men who had heard of PrEP, just over two-thirds (68%) had heard of ED-PrEP, and of those who had heard of it, less than half (44%) knew how to take ED-PrEP correctly as per clinical guidelines. We recommend further work to increase awareness and knowledge of ED-PrEP to promote effective use to prevent HIV infection.

SH22028Sexual and reproductive health and rights in the era of COVID-19: a qualitative study of the experiences of vulnerable urban youth in Ethiopia

Nicola Jones, Kate Pincock 0000-0002-8263-7720, Workneh Yadete, Meron Negussie, Estibel Mitiku and Tsinu AmdeSelassie
pp. 509-516

The COVID-19 pandemic and associated lockdowns in Ethiopia have had severe consequences for the sexual health of vulnerable urban youth. The paper finds that young people with HIV, disabilities, involved in commercial sex work and living on the streets face increased levels of sexual violence, limited access to sexual and reproductive health information and services, and loss of livelihoods. Strategies to protect urban young people’s sexual health and rights must include reopening health services promptly and improving social protection coverage.

SH21250Lifetime cost of HIV management in Australia: an economic model

Megumi Lim 0000-0002-6881-0152, Angela Devine 0000-0002-3321-8706, Richard T. Gray, Jisoo A. Kwon, Jolie L. Hutchinson and Jason J. Ong 0000-0001-5784-7403
pp. 517-524

Although increasing access to antiretroviral therapy (ART) for HIV has significantly reduced morbidity and mortality, treating persons living with HIV can be challenging and costly. This study estimates the lifetime cost of HIV management from the Australian healthcare perspective. The average discounted lifetime cost of HIV management was A$282 093, and the largest contributor to lifetime cost was ART (92%). This high lifetime cost highlights the urgent investment needed to prevent new infections of HIV.

SH22109Sustaining sexual and reproductive health through COVID-19 pandemic restrictions: qualitative interviews with Australian clinicians

Christy E. Newman 0000-0002-5482-2822, Doug Fraser, Jason J. Ong 0000-0001-5784-7403, Christopher Bourne, Andrew E. Grulich and Benjamin R. Bavinton
pp. 525-532

Health services were profoundly impacted by coronavirus disease 2019 (COVID-19) restrictions, and difficult choices were made to sustain essential services for people with HIV and those at risk of HIV. We interviewed clinicians working in sexual and reproductive health services around Australia, who described the most important adaptations as being related to triage, teamwork, telehealth and trust. Insights gained from service adaptations caused by COVID-19 have the potential to drive long-term innovations in the sexual and reproductive healthcare sector.

SH22085Physical function limitation among gay and bisexual men aged ≥55years with and without HIV: findings from the Australian Positive and Peers Longevity Evaluation Study (APPLES)

David C. Boettiger 0000-0002-5951-4503, Md. Hamidul Huque, Mark Bloch, Ian Woolley 0000-0003-2928-1291, David J. Templeton, Matthew G. Law, Neil Fraser, Jennifer Hoy and Kathy Petoumenos
pp. 533-545

We assessed physical function among gay and bisexual men in Australia aged ≥55 years using a self-administered survey. The survey was completed by 381 men: 186 without HIV and 195 with HIV. Compared with men without HIV, those with HIV had higher proportions of severe (13.3% vs 8.1%) and moderate-to-severe (26.7% vs 24.2%) physical function limitation. The mechanisms underlying this association require investigation, particularly given the rapidly increasing age of the HIV population.


The sexual network constitutes the pathway of HIV transmission, and it is crucial for understanding and preventing the spread of HIV. The results showed that the sexual network variables of partner age, partner marital status, partner type and relationship stability were significantly associated with risky sexual behaviours. Future research should focus on the determinants of structured sexual networks and identify key groups at risk for cross-population HIV transmission to improve intervention measures.

SH22046Evaluating the time of HIV infection, diagnosis and treatment delays based on HIV notification data in Northwest China, 2008–19

Rui Zhao 0000-0002-1257-9617, Hailan Zhang, Xin Zhao, Tianyi Zhuang, Christopher K. Fairley 0000-0001-9081-1664, Jason J. Ong 0000-0001-5784-7403, Shiyi He, Lu Bai, Jane Hocking 0000-0001-9329-8501, Lei Zhang 0000-0003-2343-084X, Xiaoli Wei and Guihua Zhuang
pp. 556-565

We estimate the time from HIV infection to initiation of ART and the proportion of undiagnosed HIV infections, based on HIV notification data from Northwest China during 2008–19 and found: first, we estimated about that two-thirds of HIV cases remain undiagnosed and this proportion was even higher among heterosexuals; and second, the time from HIV diagnosis to ART initiation has reduced significantly over the past decade.

SH22140Slamsex in The Netherlands among men who have sex with men (MSM): use patterns, motives, and adverse effects

Leon Knoops 0000-0002-8041-7855, Jan van Amsterdam 0000-0002-8847-4387, Thijs Albers, Tibor Markus Brunt and Wim van den Brink
pp. 566-573

About 0.5–3.1% of men who have sex with men (MSM) self inject drugs before or during sex (‘slamming’). Our survey among 175 Dutch MSM, who had practised slamsex, reported various adverse health effects associated with slamsex (skin problems, collapsed veins, infections, and psychological symptoms, like insomnia, sadness, depressed mood, anxiety, suicidal tendencies and loss of control). The current information of slamsex by MSM may contribute to the reinforcement of accessible, non-judgmental and well informed prevention and harm reduction activities.


The COVID-19 pandemic and its related infection control measures might alter individuals’ sexual health practices and dating app usage. There was a decline in sexual activities with non-regular sexual partners during the pandemic while dating apps were used more frequently. Interventions to promote sexual well-being during the pandemic should be considered.

SH22070Under-utilisation of cardioprotective glucose-lowering medication in diabetics living with HIV

Bakani Butale 0000-0003-0582-8694, Ian Woolley 0000-0003-2928-1291, Kathryn Cisera, Tony Korman and Georgia Soldatos
pp. 580-582

Diabetes is increasingly common among people living with HIV (PLWH). Given new evidence demonstrating cardiovascular benefits of sodium glucose transporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP1 RA) in diabetic patients, we reviewed medical charts of PLWH at Monash Health to determine the rates of their use and found that only 4% of diabetic patients were receiving SGLT2i and 19% were receiving GLP1 RA. Prescribers should carefully consider their choice of glucose-lowering medication when treating PLWH.

Committee on Publication Ethics